Body dysmorphic disorder: Diagnosis and treatment of imagined ugliness

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 8, 1996, Pages 61-65

  Phillips, Katharine A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; BODY IMAGE; CASE REPORT; COGNITIVE THERAPY; FACE DYSMORPHIA; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; CLOMIPRAMINE; COGNITIVE THERAPY; DRUG THERAPY, COMBINATION; FEMALE; FLUVOXAMINE; HUMANS; MALE; PSYCHOTROPIC DRUGS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS; TREATMENT OUTCOME;

EID: 0029810910     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry 1991;148:1138-1149
2. Phillips KA, McElroy SL, Keck PE Jr, et al. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993;150:302-308
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
4. Simeon D, Hollander E, Stein OJ, et al. Body dysmorphic disorder in the DSM-IV Field Trial for obsessive compulsive disorder. Am J Psychiatry 1995;152:1207-1209
5. Brawman-Mintzer O, Lydiard RE, Phillips KA, et al. Body dysmorphic disorder: a comorbidity study. Am J Psychiatry 1995;152:1665-1667
6. Phillips KA, Gunderson CG, Mallya G, et al. A comparison study of body dysmorphic disorder and obsessive compulsive disorder. In: Abstracts of Panels and Posters of the 33rd Annual Meeting of the American College of Neuropsychopharmacology; December 12-16, 1994; San Juan, Puerto Rico. Page 155
7. Phillips KA, Nierenberg AA, Fava M. Body dysmorphic disorder in atypical depression. J Nerv Ment Dis. In press
8. Hollander E, Cohen LJ, Simeon D. Body dysmorphic disorder. Psychiatric Annals 1993;23:359-364
9. Phillips KA, McElroy SL. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications. J Nerv Ment Dis 1993;181:699-702
10. Phillips KA, McElroy SL, Keck PE Jr, et al. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994;30:179-186
11. Fukuda O. Statistical analysis of dysmorphophobia in out-patient clinic. Japanese Journal of Plastic and Reconstructive Surgery 1977;20:569-577
12. Barr LC, Goodman WK, Price LH. Acute exacerbation of body dysmorphic disorder during tryptophan depletion [letter]. Am J Psychiatry 1992;149:1406-1407
13. Hollander E, Phillips KA. Body image and experience disorders: body dysmorphic and depersonalization disorders. In: Hollander E, ed. Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Press; 1992
14. Phillips KA, McElroy SL, Hudson JI, et al. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry 1995;56(suppl 4):41-51
15. Phillips KA. Body dysmorphic disorder: clinical features and drug treatment. CNS Drugs 1995;3:30-40
16. Phillips KA, McElroy SL, Lion JR. Body dysmorphic disorder in cosmetic surgery patients [letter]. Journal of Plastic and Reconstructive Surgery 1992;90:333-334
17. Hollander E, Liebowitz MR, Winchel R, et al. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am J Psychiatry 1989; 146:768-770
18. Hollander E, Cohen L, Simeon D, et al. Fluvoxamine treatment of body dysmorphic disorder [letter]. J Clin Psychopharmacology 1994;14: 75-77
19. Phillips KA, McElroy SL. An open-label study of fluvoxamine in body dysmorphic disorder. In: Scientific Abstracts of the 34th Annual Meeting of the American College of Neuropsychopharmacology; December 11-15, 1995; San Juan, Puerto Rico. Page 239
20. Eisen JL, Phillips KA, Beer D, et al. Assessment of insight in obsessions and delusions. In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association; May 25, 1993; San Francisco, Calif. Abstract NR359:149
21. Phillips KA. A preliminary open study of buspirone augmentation of SRIs in body dysmorphic disorder. In: Abstracts of Posters and Presentations of the 35th Annual Meeting of the New Clinical Drug Evaluation Unit Program (NCDEU); May 31-June 3, 1994; Orlando, Fla: National Institute of Mental Health. Page 41
22. Neziroglu FA, Yaryura-Tobias JA. Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behavior Therapy 1993;24:431-438